{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:49:02Z","timestamp":1760986142539,"version":"3.41.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>An 84-year-old man with nonmetastatic castrate-sensitive prostate cancer was referred for a <jats:sup>68<\/jats:sup>Ga\u2013prostate-specific membrane antigen (PSMA) PET\/CT scan with a prostate-specific antigen level of 3.6 ng\/mL for restaging. He was 22 years post\u2013radical prostatectomy and had salvage radiation being managed with intermittent hormonal therapy. Imaging revealed a right lower lobe mass with increased PSMA uptake (SUV<jats:sub>max<\/jats:sub> 6.2). Biopsy and subsequent immunostaining determined the mass to be diffuse large B-cell lymphoma. We report a case of diffuse large B-cell lymphoma diagnosed in the setting of PSMA positivity, highlighting awareness for oncologists and radiologists to know this possibility.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004503","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T16:01:29Z","timestamp":1673020889000},"page":"190-191","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Prostate-Specific Membrane Antigen PET Positivity in a Lung Mass"],"prefix":"10.1097","volume":"48","author":[{"given":"Sydney A.","family":"Caputo","sequence":"first","affiliation":[{"name":"Tulane University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Jang","sequence":"additional","affiliation":[{"name":"Deming Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Talbert","sequence":"additional","affiliation":[{"name":"Department of Radiology, Tulane University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nakhle S.","family":"Saba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Sartor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20250621","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","year":"1997","journal-title":"Clin Cancer Res"},{"key":"bib2-20250621","first-page":"3192","article-title":"Five different anti\u2013prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature","volume":"59","year":"1999","journal-title":"Cancer Res"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/RLU.0000000000001378","article-title":"Prostate-specific membrane antigen uptake in small cleaved B-cell follicular non-Hodgkin lymphoma","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/RLU.0000000000002727","article-title":"Concomitant prostate carcinoma and follicular lymphoma: \u201cflip-flop\u201d appearances on PSMA and FDG PET\/CT scans","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/RLU.0000000000001169","article-title":"Follicular lymphoma showing avid uptake on 68Ga PSMA-HBED-CC PET\/CT","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/RLU.0000000000003828","article-title":"Positive multifocal PSMA PET\/CT in a patient with prostate cancer and follicular lymphoma","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1097\/MNM.0000000000001465","article-title":"Head-to-head comparison between 68Ga-PSMA and 18F-FDG-PET\/CT in lymphomas: a preliminary analysis","volume":"42","year":"2021","journal-title":"Nucl Med Commun"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.juro.2015.12.025","article-title":"Diagnostic efficacy of (68)gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate Cancer","volume":"195","year":"2016","journal-title":"J Urol"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","year":"2020","journal-title":"Lancet"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:01:18Z","timestamp":1750536078000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004503"}},"subtitle":["Diagnosis of Diffuse Large B-Cell Lymphoma"],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004503","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2023,2]]}}}